← Back
Data updated: Mar 10, 2026
ANDAS 5 HOLDING
Neurology
ANDAS 5 HOLDING is a generic drug manufacturer focused on Neurology. Key products include LABETALOL HYDROCHLORIDE.
1997
Since
4
Drugs
-
Trials
15
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
BACLOFEN 2025-11-21
Manufacturing (CMC)
LABETALOL HYDROCHLORIDE 2025-10-02
LABETALOL HYDROCHLORIDE 2025-09-23
LABETALOL HYDROCHLORIDE 2025-06-06
Manufacturing (CMC)
BACLOFEN 2025-06-03
Manufacturing (CMC)
BACLOFEN 2025-06-03
Manufacturing (CMC)
LABETALOL HYDROCHLORIDE 2025-05-07
Labeling
BACLOFEN 2025-03-03
Labeling
BACLOFEN 2024-12-06
BACLOFEN 2024-10-24
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 1997-05-30
- Latest
- 2025-06-03
- Applications
- 4